We are live on ! Find out more
BLFS icon

BioLife Solutions

156 hedge funds and large institutions have $897M invested in BioLife Solutions in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 61 increasing their positions, 53 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

15% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 53

5% more capital invested

Capital invested by funds: $850M → $897M (+$46.6M)

2.63% more ownership

Funds ownership: 90.67%93.3% (+2.6%)

8% less funds holding

Funds holding: 169156 (-13)

59% less call options, than puts

Call options by funds: $570K | Put options by funds: $1.38M

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Holders
156
Holders Change
-13
Holders Change %
-7.69%
% of All Funds
2.45%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
9
Increased
61
Reduced
53
Closed
22
Calls
$570K
Puts
$1.38M
Net Calls
-$809K
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
176
Simplex Trading
Illinois
-$1.5K -71 Closed

BLFS Hedge Fund Activity: Q2 2023 in Review

156 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2023, worth a combined $897M — up 5.5% from $850M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BLFS and 9 opened new positions — a net loss of 13 holders — while 53 trimmed existing stakes and 61 added.

The largest buyer was Park West Asset Management, adding an estimated $13.2M. The largest seller was Mirabella Financial Services, exiting entirely with an estimated $7.28M sold.

  • 156 institutional investors held BioLife Solutions (BLFS) as of Q2 2023, down from 169 in Q1 2023.
  • Funds reported $897M of BioLife Solutions stock for Q2 2023, up 5.5% quarter-over-quarter.
  • 9 funds opened new BioLife Solutions positions in Q2 2023 and 22 closed out, a net change of -13 holders.
  • The largest BioLife Solutions buyer in Q2 2023 was Park West Asset Management, an estimated $13.2M added.
  • The largest BioLife Solutions seller in Q2 2023 was Mirabella Financial Services, an estimated $7.28M sold.

Based on aggregated 13F filings for Q2 2023.